Chargement en cours...
Alemtuzumab for multiple sclerosis
BACKGROUND: Multiple sclerosis (MS) is an autoimmune, T‐cell‐dependent, inflammatory, demyelinating disease of the central nervous system, with an unpredictable course. Current MS therapies focus on treating exacerbations, preventing new exacerbations and avoiding the progression of disability. Howe...
Enregistré dans:
| Publié dans: | Cochrane Database Syst Rev |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons, Ltd
2016
|
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6486037/ https://ncbi.nlm.nih.gov/pubmed/27082500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011203.pub2 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|